Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among prem…
- United Hospital Center — Bridgeport, West Virginia
- WVUH-Berkely Medical Center — Martinsburg, West Virginia
- West Virginia University Healthcare — Morgantown, West Virginia
- Camden Clark Medical Center — Parkersburg, West Virginia
- Princeton Community Hospital — Princeton, West Virginia